Alzamend Neuro (ALZN) Net Shares Issued and Repurchased (2020 - 2026)

Alzamend Neuro has disclosed Net Shares Issued and Repurchased across 7 years of filings, most recently posting $1.6 million for Q2 2026.

• In Q2 2026, Net Shares Issued and Repurchased rose 429629.73% year-over-year to $1.6 million; the TTM figure through Apr 2026 stood at $1.6 million (up 429629.73% YoY), while the FY2026 annual figure was $1.6 million, up 429629.73% from the prior year.
• Net Shares Issued and Repurchased came in at $1.6 million for Q2 2026 at Alzamend Neuro, up from $370.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $2.4 million in Q2 2023 to a low of $370.0 in Q2 2025.
• Average Net Shares Issued and Repurchased over 5 years is $1.0 million, with a median of $1.1 million recorded in 2022.
• Year-over-year, Net Shares Issued and Repurchased sank 99.97% in 2024 and soared 429629.73% in 2026.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.1 million in 2022, then jumped by 117.42% to $2.4 million in 2023, then sank by 99.86% to $3333.0 in 2024, then plunged by 88.9% to $370.0 in 2025, then soared by 429629.73% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.6 million in Q2 2026, $370.0 in Q2 2025, and $3333.0 in Q3 2024.